Floatz logo

Duloxetine

Fibromyalgia

Cukurova UniversitySmall moleculePhase 4 / ApprovedActive
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
64/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Fibromyalgia cohort.

Asset / SponsorPhaseRating
Pregabalin
Yung Shin Pharm. Ind. Co., Ltd.
Phase 4BB
PIPERAZINE, 1-(BIS(4-FLUOROPHENYL)METHYL)-4-(3-PHENYL-2-PROPENYL)-, (E)-
Taipei Veterans General Hospital, Taiwan
Phase 4BB
Lidocaine
Peking University Third Hospital
Phase 2BB
Mirogabalin
Daiichi Sankyo
Phase 3B
Gabapentin
Good Samaritan Regional Medical Center, Oregon
Phase 3B

View all 33 →

Same molecule, other indications

Duloxetine is also rated in:

diabetic neuropathyActive
A
Indicative · Phase 4
81 / 100
View asset →
osteoarthritisActive
BBB
Indicative · Phase 4
72 / 100
View asset →
irritable bowel syndromeDormant
BBB
Indicative · Phase 4
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →